U.S. pharma big copyright scrapped two experimental weight loss products previous yr—a as soon as-day by day pill, lotiglipron, due to elevated liver enzymes along with a two times-every day pill, danuglipron, due to strong Unintended effects—but CEO Albert Bourla has said the company is decided to “play and get” while in the weight problem